Helsby, N. A., Lo, W., Sharples, K., Riley, G., Murray, M., Spells, K., . . . Findlay, M. (2008). CYP2C19 pharmacogenetics in advanced cancer: Compromised function independent of genotype. British journal of cancer, 99(8), 1251-1255. https://doi.org/10.1038/sj.bjc.6604699
Citace podle Chicago (17th ed.)Helsby, N A., W-Y Lo, K. Sharples, G. Riley, M. Murray, K. Spells, M. Dzhelai, A. Simpson, a M. Findlay. "CYP2C19 Pharmacogenetics in Advanced Cancer: Compromised Function Independent of Genotype." British Journal of Cancer 99, no. 8 (2008): 1251-1255. https://doi.org/10.1038/sj.bjc.6604699.
Citace podle MLA (9th ed.)Helsby, N A., et al. "CYP2C19 Pharmacogenetics in Advanced Cancer: Compromised Function Independent of Genotype." British Journal of Cancer, vol. 99, no. 8, 2008, pp. 1251-1255, https://doi.org/10.1038/sj.bjc.6604699.